Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Holman

Showing results (481-490 of 716) with videos related to

Pageof 72
Sort By:
The American Journal of Cardiology|September 23, 2008
Comparison of left atrial volumes and function by real-time three-dimensional echocardiography in patients having catheter ablation for atrial fibrillation with persistence of sinus rhythm versus recurrent atrial fibrillation three months laterNina Ajmone Marsan, Laurens F Tops, Eduard R Holman, et al.
Cardiovascular Diabetology|September 5, 2019
Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOSMichael A Nauck, Darren K McGuire, Karen S Pieper, et al.
Journal of Cardiovascular Electrophysiology|July 30, 2005
Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Gabe B Bleeker, et al.
Journal of the American College of Cardiology|December 20, 2005
Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapyGabe B Bleeker, Martin J Schalij, Petros Nihoyannopoulos, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 5, 2017
First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on HemostasisReheman Adili, Benjamin E Tourdot, Katherine Mast, et al.
Bioorganic & Medicinal Chemistry|February 23, 2016
A potent and selective inhibitor targeting human and murine 12/15-LOXMichelle M Armstrong, Cody J Freedman, Joo Eun Jung, et al.
Heart (British Cardiac Society)|October 16, 2007
Optimal use of echocardiography in cardiac resynchronisation therapyGabe B Bleeker, Cheuk-Man Yu, Petros Nihoyannopoulos, et al.
Diabetologia|November 24, 2014
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunctionDavid A Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Proteomic Pathways across Ejection Fraction Spectrum in Heart Failure: an EXSCEL SubstudyAnthony E Peters, Maggie Nguyen, Jennifer B Green, et al.
Heart Rhythm|September 4, 2007
Does left ventricular dyssynchrony immediately after acute myocardial infarction result in left ventricular dilatation?Sjoerd A Mollema, Gabe B Bleeker, Su San Liem, et al.
Pageof 72

Showing results (481-490 of 716) with videos related to

Sort By:
Pageof 72
The American Journal of Cardiology|September 23, 2008
Comparison of left atrial volumes and function by real-time three-dimensional echocardiography in patients having catheter ablation for atrial fibrillation with persistence of sinus rhythm versus recurrent atrial fibrillation three months laterNina Ajmone Marsan, Laurens F Tops, Eduard R Holman, et al.
Cardiovascular Diabetology|September 5, 2019
Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOSMichael A Nauck, Darren K McGuire, Karen S Pieper, et al.
Journal of Cardiovascular Electrophysiology|July 30, 2005
Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Gabe B Bleeker, et al.
Journal of the American College of Cardiology|December 20, 2005
Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapyGabe B Bleeker, Martin J Schalij, Petros Nihoyannopoulos, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 5, 2017
First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on HemostasisReheman Adili, Benjamin E Tourdot, Katherine Mast, et al.
Bioorganic & Medicinal Chemistry|February 23, 2016
A potent and selective inhibitor targeting human and murine 12/15-LOXMichelle M Armstrong, Cody J Freedman, Joo Eun Jung, et al.
Heart (British Cardiac Society)|October 16, 2007
Optimal use of echocardiography in cardiac resynchronisation therapyGabe B Bleeker, Cheuk-Man Yu, Petros Nihoyannopoulos, et al.
Diabetologia|November 24, 2014
Selective inhibition of 12-lipoxygenase protects islets and beta cells from inflammatory cytokine-mediated beta cell dysfunctionDavid A Taylor-Fishwick, Jessica Weaver, Lindsey Glenn, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Proteomic Pathways across Ejection Fraction Spectrum in Heart Failure: an EXSCEL SubstudyAnthony E Peters, Maggie Nguyen, Jennifer B Green, et al.
Heart Rhythm|September 4, 2007
Does left ventricular dyssynchrony immediately after acute myocardial infarction result in left ventricular dilatation?Sjoerd A Mollema, Gabe B Bleeker, Su San Liem, et al.
Pageof 72